Sort   by:  
 Page size 
UnknownNivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
Not available
S-EPMC5569693 | biostudies-literature
UnknownEvolution of anatomic pathology workload from 2011 to 2019 assessed in a regional hospital laboratory via 574,093 pathology reports.
Not available
S-EPMC8241038 | biostudies-literature
UnknownDevelopment and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+).
Not available
S-EPMC8532207 | biostudies-literature
UnknownThe economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer.
Not available
S-EPMC9340413 | biostudies-literature
UnknownNasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial.
Not available
S-EPMC10565599 | biostudies-literature
UnknownDrosophila muller f elements maintain a distinct set of genomic properties over 40 million years of evolution.
Not available
S-EPMC4426361 | biostudies-literature
UnknownDurvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
Not available
S-EPMC7771363 | biostudies-literature
UnknownRisk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.
Not available
S-EPMC6306365 | biostudies-literature
Sort   by:  
 Page size